Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AMPICILLIN\SULBACTAM Cause Drug hypersensitivity? 70 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 70 reports of Drug hypersensitivity have been filed in association with AMPICILLIN\SULBACTAM. This represents 4.2% of all adverse event reports for AMPICILLIN\SULBACTAM.

70
Reports of Drug hypersensitivity with AMPICILLIN\SULBACTAM
4.2%
of all AMPICILLIN\SULBACTAM reports
2
Deaths
19
Hospitalizations

How Dangerous Is Drug hypersensitivity From AMPICILLIN\SULBACTAM?

Of the 70 reports, 2 (2.9%) resulted in death, 19 (27.1%) required hospitalization, and 2 (2.9%) were considered life-threatening.

Is Drug hypersensitivity Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AMPICILLIN\SULBACTAM. However, 70 reports have been filed with the FAERS database.

What Other Side Effects Does AMPICILLIN\SULBACTAM Cause?

Drug ineffective (258) Off label use (124) Pyrexia (98) Rash (98) Diarrhoea (93) Condition aggravated (83) Pneumonia (68) Acute kidney injury (66) Drug eruption (66) Pruritus (54)

What Other Drugs Cause Drug hypersensitivity?

METHOTREXATE (16,677) ETANERCEPT (12,991) ADALIMUMAB (11,599) MORPHINE (11,095) RITUXIMAB (8,924) LEFLUNOMIDE (8,148) INFLIXIMAB (8,119) TOCILIZUMAB (7,883) ABATACEPT (7,808) CODEINE (7,479)

Which AMPICILLIN\SULBACTAM Alternatives Have Lower Drug hypersensitivity Risk?

AMPICILLIN\SULBACTAM vs AMPRENAVIR AMPICILLIN\SULBACTAM vs AMPYRA AMPICILLIN\SULBACTAM vs AMRUBICIN AMPICILLIN\SULBACTAM vs AMSACRINE AMPICILLIN\SULBACTAM vs ANAGRELIDE

Related Pages

AMPICILLIN\SULBACTAM Full Profile All Drug hypersensitivity Reports All Drugs Causing Drug hypersensitivity AMPICILLIN\SULBACTAM Demographics